bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Celldex Therapeutics Inc. logo

    Celldex Therapeutics Inc.

    CLDX | NASDAQ
    Chart Builder DCF Calculator
    $34.70
    -$3.19 (-8.42%)
    Sep 22, 2026, 2:02 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $2.52B
    Enterprise Value
    $1.81B
    Beta
    0.84
    Average Volume
    919.76K
    Shares Outstanding (Diluted)
    77.84M
    Shares Change YoY
    17.24%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US15117B2025

    Price Performance

    Price Change 1M
    -5.5%
    Price Change 3M
    14.9%
    Price Change 6M
    19.6%
    Price Change YTD
    40.3%
    Price Change 1Y
    52.4%
    Price Change 3Y
    48.9%
    Price Change 5Y
    -31.4%
    1M CAGR (ann.)
    -9.2%
    1Y CAGR (ann.)
    46.2%
    5Y CAGR (ann.)
    -6.9%
    All-Time CAGR
    -9.2%

    Valuation

    PE Ratio
    -8.69
    Forward PE
    N/A
    PEG Ratio
    0.25
    Forward PEG
    -7.87
    PS Ratio
    22,510.20
    Forward PS
    256.90
    PB Ratio
    3.53
    P/FCF Ratio
    -8.16
    P/Adj. FCF Ratio
    -7.16
    P/OCF Ratio
    -12.50
    EV/Sales
    16,146.96
    EV/EBIT
    -7.96
    EV/EBITDA
    -8.05
    EV/FCF
    -5.85
    Earnings Yield
    -11.5%
    FCF Yield
    -12.3%
    Adj. FCF Yield
    -14.0%

    Financial Health

    Net Cash
    $717.59M
    Total Debt
    $4.9M
    Cash & Short-Term Investments
    $717.59M
    Total Assets
    $782.35M
    Current Ratio
    11.82
    Quick Ratio
    11.82
    Debt / Equity Ratio
    0.01
    Debt / EBITDA
    -0.02
    Debt / FCF
    -0.02
    OCF / Debt
    -61.41
    Interest Coverage
    0.00
    Altman Z-Score
    18.86
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    -56850.9%
    Operating Profit Margin
    -218963.4%
    EBITDA Margin
    -265353.6%
    Net Profit Margin
    -268385.7%
    FCF Margin
    -275932.1%
    Adj. FCF Margin
    -314471.4%
    SBC / Revenue
    30929.5%
    SBC Impact (per share)
    -14.0%

    Returns

    Return on Assets
    -38.4%
    Return on Equity
    -52.4%
    Return on Invested Capital
    -45.1%
    Return on Capital Employed
    -45.2%
    Return on Tangible Assets
    -39.8%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -67.5%
    Revenue CAGR 5Y
    -58.0%
    Revenue CAGR 10Y
    -32.3%
    EPS CAGR 3Y
    -24.0%
    EPS CAGR 5Y
    -17.2%
    EPS CAGR 10Y
    23.2%
    FCF CAGR 3Y
    -45.1%
    FCF CAGR 5Y
    -32.7%
    FCF CAGR 10Y
    -16.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    19
    EPS Growth Next 3Y
    29.9%
    Revenue Growth Next 3Y
    1521.7%
    Earnings Date
    Nov 8, 2026
    EPS Estimate (next Q)
    -$1.02
    EPS Growth Est (next Q)
    1.0%
    Revenue Est (next Q)
    $722.64K
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $63.88
    Price Target Upside
    68.6%

    Cash Flow

    Operating Cash Flow
    $-301.15M
    Free Cash Flow
    $-309.04M
    Adj. Free Cash Flow
    $-352.21M
    FCF Per Share
    -$3.11
    OCF Per Share
    -$3.03
    OCF/S Ratio
    -210326.8%

    Income Statement

    Revenue
    $112K
    Gross Profit
    $-63.7M
    Operating Income
    $-245.24M
    EBITDA
    $-224.6M
    Net Income
    $-300.59M
    EPS (Diluted)
    -$4.36
    Revenue / Employee
    $565.66
    Profit / Employee
    $-1.52M
    Employees
    198

    © 2026 bestshares.com. All rights reserved.